Galcanezumab for the preventive treatment of episodic and chronic migraine in real life: A prospective multicenter study in Colombia and Mexico, including effects on anxiety and depression—on behalf of ASOLAC
Joe Muñoz-Cerón · Karina Vélez-Jiménez · Stephanía Bohórquez-Valderrama · Ildefonso Rodríguez-Leyva · y 11 más
Background Galcanezumab is a therapeutic option for individuals with high-frequency episodic and chronic migraine. To date, there is no information regarding treatment results for Colombia and Mexico. The aim of this study was to determine the effectiveness and tolerability of galcanezumab in real-life patients from Co...
- SAGE Publications
- English
- DOI: 10.1177/25158163261418597